Clinical Trials Browser

Solid Tumours × Clear all

NCT04529122 2026-05-27

A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test

Other solid neoplasm

Solid Tumours

NCT07446855 2026-05-26

PARTHENON

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumours

NCT07160725 2026-05-15

A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumours

NCT06725758 2026-05-08

TEADES

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumours

NCT06581432 2026-04-29

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

Phase 2 Recruiting

Other solid neoplasm

Solid Tumours

NCT06619509 2026-04-14

A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumours

NCT06589414 2026-02-10

DAMeGe

Phase NA Active not recruiting

Other solid neoplasm

Solid Tumours

NCT07165067 2025-12-29

A Study of AP601 in Patients With Locally Unresectable Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumours

NCT06815575 2025-12-17

A Safety and Pharmacokinetics Study of RC220 Combined With Doxorubicin in Adult Participants With Solid Tumours.

Phase 1 Recruiting

Other solid neoplasm

Solid Tumours

NCT03572192 2025-11-18

Tissue Collection Framework To Improve Outcomes In Solid Tumours

Other solid neoplasm

Solid Tumours

NCT02360345 2024-09-26

ONX-0801

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT06231277 2024-01-30

BH002-Ⅰ-101

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT03150056 2022-08-10

Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate Cancer

Phase 1 Terminated

73 enrolled 34 charts

Other solid neoplasm

Solid Tumours

NCT01948297 2020-09-09

Debio 1347-101 Phase I Trial in Advanced Solid Tumours With Fibroblast Growth Factor Receptor (FGFR) Alterations

Phase 1 Terminated

Other solid neoplasm

Solid Tumours

NCT04179071 2020-07-07

A Study in Healthy Male Subjects to Understand How Savolitinib Behaves Inside the Body (Pharmacokinetics) When Administered Alone and in Combination With Famotidine

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT03702036 2020-04-13

Compassionate Use Individual Request Program for GSK525762 in NUT Midline Carcinoma

No longer available

Other solid neoplasm

Solid Tumours

NCT02264418 2020-01-18

KIDES-203

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT03333824 2019-03-25

Effects of AZD1775 on the PK Substrates for CYP3A, CYP2C19, CYP1A2 and on QT Interval in Patients With Advanced Cancer

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT03415100 2018-08-01

Pilot Study of NKG2D-Ligand Targeted CAR-NK Cells in Patients With Metastatic Solid Tumours

Phase 1 Unknown

Other solid neoplasm

Solid Tumours

NCT03315091 2018-04-30

Phase I Study to Assess the Effect of Food on AZD1775 Pharmacokinetics in Patients With Advanced Solid Tumours

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT01998607 2018-01-09

Survey of XGEVA® Presrcibers in Europe to Evaluate Their Knowledge of the Summary of Product Characteristics Pertaining to Osteonecrosis of the Jaw

Other solid neoplasm

Solid Tumours

NCT00732420 2017-11-13

Open-label Study of Topotecan and Pazopanib in Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT00136578 2017-09-25

Ispinesib In Combination With Carboplatin In Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT00742131 2017-07-31

A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally to Subjects With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT00743067 2017-07-26

A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT00695448 2017-07-25

Phase I Open-Label, Dose-Escalation Study of GSK1059615 in Patients With Solid Tumors or Lymphoma

Phase 1 Terminated

Other solid neoplasm

Solid Tumours

NCT00742261 2017-07-07

A Bioavailability Study of GSK1363089 in Subjects With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT02215850 2016-05-17

Safety Study of SLC-0111 in Subjects With Advanced Solid Tumours

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT01209091 2016-02-03

Utility and Work Productivity Data for Economic Evaluation of Breast Cancer Therapies in the Netherlands and Sweden

Other solid neoplasm

Solid Tumours

NCT02056392 2015-11-09

To Assess the Effects of Single Oral Dose of Selumetinib [AZD6244; ARRY-142886] [Hyd-Sulfate]), on QTc Interval in Healthy Male Volunteers

Phase 1 Completed

54 enrolled 31 charts

Other solid neoplasm

Solid Tumours

NCT01931761 2015-06-30

Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C] Selumetinib in Volunteers

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT02093728 2015-06-30

To Assess the Effect of Itraconazole and Fluconazole on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT01974349 2014-08-13

To Assess the Effect of Food on the Pharmacokinetics of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Healthy Male Volunteers

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT02046850 2014-04-29

To Assess the Effect of Rifampicin on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT00497679 2009-05-14

AZD1152 in Patients With Advanced Solid Malignancies-Study 3

Phase 1 Terminated

Other solid neoplasm

Solid Tumours